Identification of New Therapeutic Targets by Genome-Wide Analysis of Gene Expression in the Ipsilateral Cortex of Aged Rats after Stroke

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Buga, Ana Maria ^a,b   Scholz, Claus Jürgen ^c   Kumar, Senthil ^d   Herndon, James G ^e   Alexandru, Dragos ^b   Cojocaru, Gabriel Radu ^b   Dandekar, Thomas ^f   Popa Wagner, Aurel ^a  

^a Faculty of Medicine   (Germany)

^b UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d IOWA STATE UNIVERSITY   (United States)

^e EMORY UNIVERSITY   (United States)

^f NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ACVR1C GENE; ADAM 17 GENE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN CORTEX; BRAIN REGION; CALCRL GENE; CEBPA GENE; CEREBROVASCULAR ACCIDENT; CFD GENE; CONTROLLED STUDY; CORT GENE; CYP11B1 GENE; DNA DAMAGE; DOWN REGULATION; EMBRYO DEVELOPMENT; ENERGY METABOLISM; FCGR2B GENE; FCGR3A GENE; GENE; GENE CLUSTER; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TARGETING; GENETIC TRANSCRIPTION; GENOME ANALYSIS; GPNMB GENE; HOMEOSTASIS; HTR2B GENE; IMMUNE RESPONSE; LIPID METABOLISM; MMP14 GENE; MOUSE; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTOSIS; PNOC GENE; PRCP GENE; PROTEIN DEGRADATION; SCAR FORMATION; TNFRSF26 GENE; UPREGULATION; WOUND HEALING;

AGE FACTORS; AGING; ANIMALS; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; GENE EXPRESSION; RATS; RATS, SPRAGUE-DAWLEY; STROKE;

ANIMALIA; RATTUS;

EID: 84871246768     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050985     Document Type: Article

References (81)

1. Lindner MD, Gribkoff VK, Donlan NA, Jones TA, (2003) Long-lasting functional disabilities in middle-aged rats with small cerebral infarcts. J Neurosci 23: 10913-10922.
2. Markus TM, Tsai SY, Bollnow MR, Farrer RG, O'Brien TE, et al. (2005) Recovery and brain reorganization after stroke in adult and aged rats. Ann Neurol 58: 950-953.
3. Popa-Wagner A, Buga AM, Kokaia Z, (2011) Perturbed cellular response to brain injury during aging. Ageing Res Rev 10: 71-79.
4. Lu A, Tang Y, Ran R, Clark JF, Aronow BJ, et al. (2003) Genomics of the periinfarction cortex after focal cerebral ischemia. J Cereb Blood Flow Metab 23: 786-810.
5. Schmidt-Kastner R, Zhang B, Belayev L, Khoutorova L, Amin R, et al. (2002) DNA microarray analysis of cortical gene expression during early recirculation after focal brain ischemia in rat. Brain Res Mol Brain Res 108: 81-93.
6. Tseveleki V, Rubio R, Vamvakas SS, White J, Taoufik E, et al. (2010) Comparative gene expression analysis in mouse models for multiple sclerosis, Alzheimer's disease and stroke for identifying commonly regulated and disease-specific gene changes. Genomics 96: 82-91.
7. Li S, Overman JJ, Katsman D, Kozlov SV, Donnelly CJ, et al. (2010) An age-related sprouting transcriptome provides molecular control of axonal sprouting after stroke. Nat Neurosci 13: 1496-1504.
8. Buga AM, Sascau M, Pisoschi C, Herndon JG, Kessler C, et al. (2008) The genomic response of the ipsilateral and contralateral cortex to stroke in aged rats. J Cell Mol Med 12: 2731-2753.
9. Popa-Wagner A, Schroder E, Schmoll H, Walker LC, Kessler C, (1999) Upregulation of MAP1B and MAP2 in the rat brain after middle cerebral artery occlusion: effect of age. J Cereb Blood Flow Metab 19: 425-434.
10. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
11. Irizarry RA, Ooi SL, Wu Z, Boeke JD, (2003) Use of mixture models in a microarray-based screening procedure for detecting differentially represented yeast mutants. Stat Appl Genet Mol Biol. 2: Article1.
12. Kendziorski CM, Newton MA, Lan H, Gould MN, (2003) On parametric empirical Bayes methods for comparing multiple groups using replicated gene expression profiles. Stat Med. 22: 3899-38914.
13. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
14. Welt C, Sidis Y, Keutmann H, Schneyer A, (2002) Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp Biol Med (Maywood) 227: 724-752.
15. Martinez-Ferrer M, Afshar-Sherif AR, Uwamariya C, de Crombrugghe B, Davidson JM, et al. (2010) Dermal transforming growth factor-beta responsiveness mediates wound contraction and epithelial closure. Am J Pathol 176: 98-107.
16. Liu RZ, Denovan-Wright EM, Degrave A, Thisse C, Thisse B, et al. (2004) Spatio-temporal distribution of cellular retinol-binding protein gene transcripts (CRBPI and CRBPII) in the developing and adult zebrafish (Danio rerio). Eur J Biochem 271: 339-348.
17. Calcraft PJ, Ruas M, Pan Z, Cheng X, Arredouani A, et al. (2009) NAADP mobilizes calcium from acidic organelles through two-pore channels. Nature 459: 596-600.
18. Tugba Durlu-Kandilci N, Ruas M, Chuang KT, Brading A, Parrington J, et al. (2010) TPC2 proteins mediate nicotinic acid adenine dinucleotide phosphate (NAADP)- and agonist-evoked contractions of smooth muscle. J Biol Chem 285: 24925-24932.
19. Liu YL, Fann CS, Liu CM, Chen WJ, Wu JY, et al. (2008) RASD2, MYH9, and CACNG2 genes at chromosome 22q12 associated with the subgroup of schizophrenia with non-deficit in sustained attention and executive function. Biol Psychiatry 64: 789-796.
20. Jackson AC, Nicoll RA, (2011) Stargazin (TARP gamma-2) is required for compartment-specific AMPA receptor trafficking and synaptic plasticity in cerebellar stellate cells. J Neurosci 31: 3939-3952.
21. Leitch B, Shevtsova O, Kerr JR, (2009) Selective reduction in synaptic proteins involved in vesicle docking and signalling at synapses in the ataxic mutant mouse stargazer. J Comp Neurol. 512: 52-73.
22. Gierten J, Ficker E, Bloehs R, Schlomer K, Kathofer S, et al. (2008) Regulation of two-pore-domain (K2P) potassium leak channels by the tyrosine kinase inhibitor genistein. Br J Pharmacol 154: 1680-1690.
23. Zong X, Schieder M, Cuny H, Fenske S, Gruner C, et al. (2009) The two-pore channel TPCN2 mediates NAADP-dependent Ca(2+)-release from lysosomal stores. Pflugers Arch 458: 891-899.
24. Saleh S, Yeung SY, Prestwich S, Pucovsky V, Greenwood I, (2005) Electrophysiological and molecular identification of voltage-gated sodium channels in murine vascular myocytes. J Physiol 568: 155-169.
25. Tuomi JM, Chidiac P, Jones DL, (2010) Evidence for enhanced M3 muscarinic receptor function and sensitivity to atrial arrhythmia in the RGS2-deficient mouse. Am J Physiol Heart Circ Physiol 298: H554-561.
26. Martinowich K, Schloesser RJ, Jimenez DV, Weinberger DR, Lu B, (2011) Activity-dependent brain-derived neurotrophic factor expression regulates cortistatin-interneurons and sleep behavior. Mol Brain 4: 11.
27. Chiou LC, Liao YY, Fan PC, Kuo PH, Wang CH, et al. (2007) Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications. Curr Drug Targets 8: 117-135.
28. Siehler S, Nunn C, Hannon J, Feuerbach D, Hoyer D, (2008) Pharmacological profile of somatostatin and cortistatin receptors. Mol Cell Endocrinol 286: 26-34.
29. Wunder F, Rebmann A, Geerts A, Kalthof B, (2008) Pharmacological and kinetic characterization of adrenomedullin 1 and calcitonin gene-related peptide 1 receptor reporter cell lines. Mol Pharmacol 73: 1235-1243.
30. DaCosta Byfield S, Major C, Laping NJ, Roberts AB, (2004) SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7. Mol Pharmacol. 65: 744-752.
31. Welt C, Sidis Y, Keutmann H, Schneyer A, (2002) Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp Biol Med (Maywood) 227: 724-752.
32. Kennett GA, Trail B, Bright F, (1998) Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated. Neuropharmacology 37: 1603-1610.
33. Deussing JM, Kuhne C, Putz B, Panhuysen M, Breu J, et al. (2007) Expression profiling identifies the CRH/CRH-R1 system as a modulator of neurovascular gene activity. J Cereb Blood Flow Metab 27: 1476-1495.
34. Trumbach D, Graf C, Putz B, Kuhne C, Panhuysen M, et al. (2010) Deducing corticotropin-releasing hormone receptor type 1 signaling networks from gene expression data by usage of genetic algorithms and graphical Gaussian models. BMC Syst Biol 4: 159.
35. Hemley CF, McCluskey A, Keller PA, (2007) Corticotropin releasing hormone-a GPCR drug target. Curr Drug Targets 8: 105-115.
36. Shariat-Madar Z, Mahdi F, Schmaier AH, (2002) Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator. J Biol Chem 277: 17962-17969.
37. Zhang GX, Wang BJ, Ouyang JZ, Deng XY, Ma X, et al. (2010) Polymorphisms in CYP11B2 and CYP11B1 genes associated with primary hyperaldosteronism. Hypertens Res 33: 478-484.
38. Kagerer SM, Eichholz C, Johren O, (2011) Orexins/hypocretins increase the promoter activity of selective steroidogenic enzymes. Peptides 32: 839-843.
39. Moore EL, Gingell JJ, Kane SA, Hay DL, Salvatore CA, (2010) Mapping the CGRP receptor ligand binding domain: tryptophan-84 of RAMP1 is critical for agonist and antagonist binding. Biochem Biophys Res Commun 394: 141-145.
40. Zhou C, Garcia-Calvo M, Pinto S, Lombardo M, Feng Z, et al. (2010) Design and synthesis of prolylcarboxypeptidase (PrCP) inhibitors to validate PrCP as a potential target for obesity. J Med Chem 53: 7251-7263.
41. Kurnellas MP, Nicot A, Shull GE, Elkabes S, (2005) Plasma membrane calcium ATPase deficiency causes neuronal pathology in the spinal cord: a potential mechanism for neurodegeneration in multiple sclerosis and spinal cord injury. FASEB J 19: 298-300.
42. Badan I, Platt D, Kessler C, Popa-Wagner A, (2003) Temporal dynamics of degenerative and regenerative events associated with cerebral ischemia in aged rats. Gerontology 49: 356-365.
43. Tanaka M, Krutzik SR, Sieling PA, Lee DJ, Rea TH, et al. (2009) Activation of Fc gamma RI on monocytes triggers differentiation into immature dendritic cells that induce autoreactive T cell responses. J Immunol 183: 2349-2355.
44. Jang JE, Hidalgo A, Frenette PS, (2012) Intravenous immunoglobulins modulate neutrophil activation and vascular injury through FcγRIII and SHP-1. Circ Res. 110: 1057-1066.
45. Li F, Ravetch JV, (2011) Inhibitory Fcγ receptor engagement drives adjuvant and anti-tumor activities of agonistic CD40 antibodies. Science 333: 1030-1034.
46. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, et al. (2006) The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 7: 3.
47. Badan I, Dinca I, Buchhold B, Suofu Y, Walker L, et al. (2004) Accelerated accumulation of N- and C-terminal beta APP fragments and delayed recovery of microtubule-associated protein 1B expression following stroke in aged rats. Eur J Neurosci. 19: 2270-2280.
48. Ripoll VM, Irvine KM, Ravasi T, Sweet MJ, Hume DA, (2007) Gpnmb is induced in macrophages by IFN-gamma and lipopolysaccharide and acts as a feedback regulator of proinflammatory responses. J Immunol 178: 6557-6566.
49. Lewis J, Golde TE, (2010) Sorting out frontotemporal dementia? Neuron 68: 601-603.
50. Huang JJ, Ma WJ, Yokoyama S, (2012) Expression and immunolocalization of Gpnmb, a glioma-associated glycoprotein, in normal and inflamed central nervous systems of adult rats. Brain Behav 2: 85-96.
51. Morikis D, Lambris JD, (2002) Structural aspects and design of low-molecular-mass complement inhibitors. Biochem Soc Trans 30: 1026-1036.
52. Wang QF, Friedman AD, (2002) CCAAT/enhancer-binding proteins are required for granulopoiesis independent of their induction of the granulocyte colony-stimulating factor receptor. Blood 99: 2776-2785.
53. Popa-Wagner A, Stöcker K, Balseanu AT, Rogalewski A, Diederich K, et al. (2010) Effects of granulocyte-colony stimulating factor after stroke in aged rats. Stroke 41: 1027-1031.
54. Teronen O, Konttinen YT, Lindqvist C, Salo T, Ingman T, et al. (1997) Human neutrophil collagenase. MMP-8 in peri-implant sulcus fluid and its inhibition by clodronate. J Dent Res 76: 1529-1537.
55. Mertsch S, Schurgers LJ, Weber K, Paulus W, Senner V, (2009) Matrix gla protein (MGP): an overexpressed and migration-promoting mesenchymal component in glioblastoma. BMC Cancer 9: 302.
56. Kirton JP, Wilkinson FL, Canfield AE, Alexander MY, (2006) Dexamethasone downregulates calcification-inhibitor molecules and accelerates osteogenic differentiation of vascular pericytes: implications for vascular calcification. Circ Res 98: 1264-1272.
57. Ludwig A, Hundhausen C, Lambert MH, Broadway N, Andrews RC, et al. (2005) Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules. Comb Chem High Throughput Screen 8: 161-171.
58. Deshmukh HS, McLachlan A, Atkinson JJ, Hardie WD, Korfhagen TR, et al. (2009) Matrix metalloproteinase-14 mediates a phenotypic shift in the airways to increase mucin production. Am J Respir Crit Care Med 180: 834-845.
59. Borday C, Wrobel L, Fortin G, Champagnat J, Thaeron-Antono C, et al. (2004) Developmental gene control of brainstem function: views from the embryo. Prog Biophys Mol Biol 84: 89-106.
60. Cruz C, Maegawa S, Weinberg ES, Wilson SW, Dawid IB, et al. (2010) Induction and patterning of trunk and tail neural ectoderm by the homeobox gene eve1 in zebrafish embryos. Proc Natl Acad Sci U S A 107: 3564-3569.
61. Lewis J, Golde TE, (2010) Sorting out frontotemporal dementia? Neuron 68: 601-603.
62. Spoorendonk KM, Peterson-Maduro J, Renn J, Trowe T, Kranenbarg S, et al. (2008) Retinoic acid and Cyp26b1 are critical regulators of osteogenesis in the axial skeleton. Development 135: 3765-3774.
63. Fischer T, Faus-Kessler T, Welzl G, Simeone A, Wurst W, et al. (2011) Fgf15-mediated control of neurogenic and proneural gene expression regulates dorsal midbrain neurogenesis. Dev Biol 350: 496-510.
64. Islam O, Gong X, Rose-John S, Heese K, (2009) Interleukin-6 and neural stem cells: more than gliogenesis. Mol Biol Cell 20: 188-199.
65. Ghzili H, Grumolato L, Thouënnon E, Vaudry H, Anouar Y, (2006) Possible implication of the transcriptional regulator Id3 in PACAP-induced pro-survival signaling during PC12 cell differentiation. Regul Pept 137: 89-94.
66. Li S, Overman JJ, Katsman D, Kozlov SV, Donnelly CJ, et al. (2010) An age-related sprouting transcriptome provides molecular control of axonal sprouting after stroke. Nat Neurosci 13: 1496-1504.
67. Roohi J, Montagna C, Tegay DH, Palmer LE, DeVincent C, et al. (2009) Disruption of contactin 4 in three subjects with autism spectrum disorder. J Med Genet 46: 176-182.
68. Archer HL, Evans JC, Millar DS, Thompson PW, Kerr AM, et al. (2006) NTNG1 mutations are a rare cause of Rett syndrome. Am J Med Genet A 140: 691-694.
69. Little GE, Lopez-Bendito G, Runker AE, Garcia N, Pinon MC, et al. (2009) Specificity and plasticity of thalamocortical connections in Sema6A mutant mice. PLoS Biol 7: e98.
70. Chae JI, Kim J, Woo SM, Han HW, Cho YK, et al. (2009) Cytoskeleton-associated proteins are enriched in human embryonic-stem cell-derived neuroectodermal spheres. Proteomics 9: 1128-1141.
71. Greer PL, Hanayama R, Bloodgood BL, Mardinly AR, Lipton DM, et al. (2010) The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell 140: 704-716.
72. Matsuo R, Asada A, Fujitani K, Inokuchi K, (2001) LIRF, a gene induced during hippocampal long-term potentiation as an immediate-early gene, encodes a novel RING finger protein. Biochem Biophys Res Commun 289: 479-484.
73. Tanji K, Kamitani T, Mori F, Kakita A, Takahashi H, et al. (2010) TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson's disease and dementia with Lewy bodies. Neurobiol Dis 38: 210-218.
74. Yamada Y, Taketani S, Osada H, Kataoka T, (2011) Cytotrienin A, a translation inhibitor that induces ectodomain shedding of TNF receptor 1 via activation of ERK and p38 MAP kinase. Eur J Pharmacol 667: 113-119.
75. Chnari E, Nikitczuk JS, Wang J, Uhrich KE, Moghe PV, (2006) Engineered polymeric nanoparticles for receptor-targeted blockage of oxidized low density lipoprotein uptake and atherogenesis in macrophages. Biomacromolecules 7: 1796-17805.
76. Na IK, Letsch A, Guerreiro M, Bauer S, Noack I, et al. (2009) Human bone marrow as a source to generate CMV-specific CD4+ T cells with multifunctional capacity. J Immunother 32: 907-913.
77. Gavioli EC, Duarte FS, Guerrini R, Calo G, Rae GA, et al. (2008) GABA(A) signalling is involved in N/OFQ anxiolytic-like effects but not in nocistatin anxiogenic-like action as evaluated in the mouse elevated plus maze. Peptides 29: 1404-1412.
78. Lin SY, Chang WJ, Lin CS, Huang CY, Wang HF, et al. (2011) Serotonin receptor 5-HT2B mediates serotonin-induced mechanical hyperalgesia. J Neurosci 31: 1410-1418.
79. Zarrabi K, Dufour A, Li J, Kuscu C, Pulkoski-Gross A, et al. (2011) Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration. J Biol Chem 286: 33167-77.
80. Papac-Milicevic N, Breuss JM, Zaujec J, Ryban L, Plyushch T, et al. (2012) The interferon stimulated gene 12 inactivates vasculoprotective functions of NR4A nuclear receptors. Circ Res. 110: e50-63.
81. Carthagena L, Bergamaschi A, Luna JM, David A, Uchil PD, et al. (2009) Human TRIM gene expression in response to interferons. PLoS One 4: e4894.